When diet becomes a compulsion

/0 comments/in , , , /from

The increased risk of melanoma in Parkinson's patients has been documented in numerous scientific studies. A first comprehensive meta-analysis was published by Liu and colleagues in the journal Neurology in 2011 and found that people with Parkinson's had more than double the risk of being diagnosed with melanoma. An important study on this topic was also published in 2010 by John Bertoni and colleagues in the Archives of Neurology (later renamed JAMA Neurology). The Bertoni study used data from the North American Parkinson's and Melanoma Survey Group and found that the incidence of malignant melanoma was 2,24 times higher in the Parkinson's cohort compared to the general population.

Read more

LSVT BIG ©

/0 comments/in , , , /from

The increased risk of melanoma in Parkinson's patients has been documented in numerous scientific studies. A first comprehensive meta-analysis was published by Liu and colleagues in the journal Neurology in 2011 and found that people with Parkinson's had more than double the risk of being diagnosed with melanoma. An important study on this topic was also published in 2010 by John Bertoni and colleagues in the Archives of Neurology (later renamed JAMA Neurology). The Bertoni study used data from the North American Parkinson's and Melanoma Survey Group and found that the incidence of malignant melanoma was 2,24 times higher in the Parkinson's cohort compared to the general population.

Read more

Parkinson's research needs private donations

/0 comments/in , /from

Japanese scientists have developed a new blood test that can detect Parkinson's with high accuracy.

The test works by detecting a specific protein called α-synuclein that is misfolded in these diseases.

Previous tests could also detect this protein, but they required an invasive method that involved taking a sample from the spinal cord (cerebrospinal fluid). This new test can detect the protein directly in the blood, making it much easier and less invasive.

Read more

Parkinson's and skin cancer

/0 comments/in , , /from

The increased risk of melanoma in Parkinson's patients has been documented in numerous scientific studies. A first comprehensive meta-analysis was published by Liu and colleagues in the journal Neurology in 2011 and found that people with Parkinson's had more than double the risk of being diagnosed with melanoma. An important study on this topic was also published in 2010 by John Bertoni and colleagues in the Archives of Neurology (later renamed JAMA Neurology). The Bertoni study used data from the North American Parkinson's and Melanoma Survey Group and found that the incidence of malignant melanoma was 2,24 times higher in the Parkinson's cohort compared to the general population.

Read more

Optimized therapy for late motor complications in advanced Parkinson's disease

/0 comments/in , , , /from

The therapy of movement disorders in the advanced stage of idiopathic parkinsonian syndrome represents a challenge, as optimizing dopamine treatment does not always bring the expected results. It is therefore crucial to consider more intensive treatment approaches in a timely manner. As soon as signs of an advanced stage become apparent, physicians should immediately provide information about suitable therapy options and familiarize patients with possible treatment options.

Read more

The Parkinson-Bot – artificial intelligence now also in the Parkinson Journal

/1 comment/in , , , /from

In the circle of the authors and with many acquaintances and friends, whether affected by Parkinson's or not, I discussed for a long time whether we should integrate ChatGPT as a bot into our Parkinsonal Journal. 

Last but not least, we asked the "Parkinson-Bot" itself about the usefulness and it is amazing how much it reflects the different opinions from the circle mentioned above.

In the following you can read my discussion with the artificial intelligence and form your own opinion. The chat is reproduced here one to one, without any editing

Read more

Researchers are looking for ways for early Parkinson's therapy - study participants wanted

/0 comments/in , /from

 Disturbed dream sleep can indicate later Parkinson's disease. Researchers at MHH neurology are now investigating the preliminary phase of the neurodegenerative disease and are offering places for study participants.

Read more

New blood test for early detection of Parkinson's disease

/0 comments/in , , /from

Japanese scientists have developed a new blood test that can detect Parkinson's with high accuracy.

The test works by detecting a specific protein called α-synuclein that is misfolded in these diseases.

Previous tests could also detect this protein, but they required an invasive method that involved taking a sample from the spinal cord (cerebrospinal fluid). This new test can detect the protein directly in the blood, making it much easier and less invasive.

Read more

new drug pumps in prospect

/0 comments/in , /from

Oral therapies for Parkinson's are temporary because, among other things, Parkinson's disease is a progressive neurodegenerative disease. Over time, the progressive loss of dopamine-producing neurons in the brain causes symptoms to worsen. The effects of oral medications, such as levodopa, can be well controlled in the early stages of the disease. However, many patients develop fluctuations in medication efficacy over time, known as the "on-off phenomenon." These fluctuations can significantly affect quality of life and lead to unpredictable fluctuations in movement abilities.

Read more

Study shows promising results in focused ultrasound

/0 comments/in , , /from

In recent years, research has increasingly looked for new treatment options to improve the quality of life of patients. A promising study published by Prof. Dr. dr hc Günther Deuschl in the journal "InFo Neurologie + Psychiatrie" deals with the unilateral ablation of the subthalamic nucleus (STN) by magnetic resonance imaging (MRT)-guided focused ultrasound treatment (MRgFUS).

Read more